Synapse

← Cancer Research Communications

Papers in Cancer Research Communications

Page 12 · newest first

  1. Small Extracellular Vesicles Promote Stiffness-mediated MetastasisCancer Research Communications · 2024
  2. LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination DeficiencyCancer Research Communications · 2024
  3. De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 ExpressionCancer Research Communications · 2024
  4. Urolithin-A Promotes CD8+ T Cell–mediated Cancer Immunosurveillance via FOXO1 ActivationCancer Research Communications · 2024
  5. Proteasome Inhibition Reprograms Chromatin Landscape in Breast CancerCancer Research Communications · 2024
  6. Identification of Muc1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell CarcinomasCancer Research Communications · 2024
  7. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid TumorsCancer Research Communications · 2024
  8. Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic CancerCancer Research Communications · 2024
  9. Modelling Myeloma Dissemination in vitro with hMSC-Interacting Subpopulations of INA-6 Cells and their Aggregation/Detachment DynamicsCancer Research Communications · 2024
  10. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma BurdenCancer Research Communications · 2024
  11. Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognitionCancer Research Communications · 2024
  12. Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” MiceCancer Research Communications · 2024
  13. Artificial Intelligence–Assisted Cancer Status Detection in Radiology ReportsCancer Research Communications · 2024
  14. Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor MicroenvironmentCancer Research Communications · 2024
  15. Actívatexto: Feasibility and Acceptability of a Mobile Intervention That Promotes Smoking Cessation and Physical Activity among LatinosCancer Research Communications · 2024
  16. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid TumorsCancer Research Communications · 2024
  17. Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer CellsCancer Research Communications · 2024
  18. Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin TreatmentCancer Research Communications · 2024
  19. Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving RadiotherapyCancer Research Communications · 2024
  20. Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin SulfateCancer Research Communications · 2024
  21. Disparities in access to liver transplant referral and evaluation among hepatocellular carcinoma patients in GeorgiaCancer Research Communications · 2024
  22. The crosstalk between intestinal microbiota and MDSCs fuels colitis associated cancer developmentCancer Research Communications · 2024
  23. Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer AntigenCancer Research Communications · 2024
  24. High-resolution Diffusion-weighted Imaging to Detect Changes in Tumor Size and ADC, and Predict Adverse Biopsy Histology during Prostate Cancer Active SurveillanceCancer Research Communications · 2024
  25. Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid LeukemiaCancer Research Communications · 2024
  26. Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone MarrowCancer Research Communications · 2024
  27. Autophagy Inhibition–induced Cytosolic DNA Sensing Combined with Differentiation Therapy Induces Irreversible Myeloid Differentiation in Leukemia CellsCancer Research Communications · 2024
  28. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer MetastasesCancer Research Communications · 2024
  29. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine XenograftsCancer Research Communications · 2024
  30. Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 ExpressionCancer Research Communications · 2024
  31. D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A HypermethylationCancer Research Communications · 2024
  32. Healthcare Access Dimensions and Racial Disparities in End-of-Life Care Quality among Ovarian Cancer PatientsCancer Research Communications · 2024
  33. A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic ModelCancer Research Communications · 2024
  34. Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted TherapiesCancer Research Communications · 2024
  35. Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical ModelsCancer Research Communications · 2024
  36. Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2Cancer Research Communications · 2024
  37. Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of SnailCancer Research Communications · 2024
  38. Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCCancer Research Communications · 2024
  39. Immune Profiling of Vulvar Squamous Cell Cancer Discovers a Macrophage-rich Subtype Associated with Poor PrognosisCancer Research Communications · 2024
  40. The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and AdherenceCancer Research Communications · 2024
  41. Single-Cell CD4 and CD8 T Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade TherapyCancer Research Communications · 2024
  42. Drug-resilient Cancer Cell Phenotype Is Acquired via Polyploidization Associated with Early Stress Response Coupled to HIF2α Transcriptional RegulationCancer Research Communications · 2024
  43. Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung CancerCancer Research Communications · 2024
  44. Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma MetastasisCancer Research Communications · 2024
  45. Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II–III Colorectal Cancer: A Population-based StudyCancer Research Communications · 2024
  46. CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular CarcinomaCancer Research Communications · 2024
  47. Establishment and Characterization of an Epstein-Barr Virus–positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal CarcinomaCancer Research Communications · 2024
  48. Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-specific NeutrophilsCancer Research Communications · 2024
  49. Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-ICancer Research Communications · 2024
  50. Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell–intrinsic Stemness or Mesenchymality CharacteristicsCancer Research Communications · 2024